Experience of treating patients with mixed hypertriglyceridemia in a lipid center (clinical case)
-
Published:2023-01-11
Issue:4
Volume:11
Page:184-190
-
ISSN:2587-9537
-
Container-title:Complex Issues of Cardiovascular Diseases
-
language:
-
Short-container-title:Kompleks. probl. serdečno-sosud. zabol.
Author:
Sedykh D. Yu.1ORCID, Pavlova E. A.2ORCID, Hryachkova O. N.1ORCID, Kashtalap V. V.3ORCID, Barbarash O. L.3ORCID, Barbarash L. S.3ORCID
Affiliation:
1. Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases” 2. State Budgetary Healthcare Institution “Kuzbass Clinical Cardiological Hospital named after Academician L.S. Barbarash” 3. Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”; Federal State Budgetary Educational Institution of Higher Education “Kemerovo State Medical University” of the Ministry of Health of the Russian Federation
Abstract
Lipid metabolism disorders remain a significant medical and social problem associated with mortality, disability, morbidity and pathologies of the circulatory system. According to international and Russian epidemiological studies, hypertriglyceridemia is a common risk factor for coronary heart disease. Isolated use of non-pharmacological therapy and statin monotherapy is not effective enough, and therefore it is necessary to propagate the experience of combined treatment, supported by modern recommendations. This work shows the possibilities of effective use of combined therapy of lipid metabolism disorders (statin, ezetimibe, alirocumab, fenofibrate) in patients with mixed hypertriglyceridemia.
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Rehabilitation,Emergency Medicine,Surgery
Reference10 articles.
1. Boytsov S., Katapano A., Barbarash O., Yezhov M., Meshkov A., Voevoda M., Gurevich V., Kashtalap V., Duplyakov D., Vezikova N., Sadykova D. Actual issues of lipid centers’ operation in Russian Federation. Cardiovascular Therapy and Prevention. 2021; 20 (1): 2759. (In Russian) doi:10.15829/1728-8800-2021-2759 2. Meshkov A.N., Ershova A.I., Deev A.D., Metelskaya V.A., Zhernakova Yu.V., Rotar O.P., Shalnova S.A., Boytsov S.A. Distribution of lipid profile values in economically active men and women in Russian federation: results of the ESSE-RF study for the years 2012-2014. Cardiovascular Therapy and Prevention. 2017; 16 (4): 62-67. (In Russian) doi:10.15829/1728-8800-2017-4-62-67 3. Yusuf S., Hawken S., Ounpuu S. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) case-control study. Lancet. 2004; (364): 937-952. doi:10.1016/S0140-6736(04)17018-9. 4. Pogosova N.V., Oganov R.G., Boytsov S.A., Ausheva A.K., Sokolova O.Yu., Kursakov A.A., Osipova I.V., Antropova O.N., Pozdnyakov Yu.M., Salbieva A.O., Lelchuk I.N., Gusarova T.A., Gomyranova N.V., Skazin N.A., Kotseva K. Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey. Cardiovascular Therapy and Prevention. 2020; 19 (6): 2739 (In Russian) doi:10.15829/1728-8800-2020-2739 5. Yezhov M.V., Sergienko I.V., Aronov D.M., Arabidze G.G., Akhmedzhanov N.M., Bazhan S.S., Balakhonova T.V., Barbarash O.L., Boytsov S.A., Bubnova M.G., Voevoda M.I., Galyavich A.S., Gornyakova N.B., Gurevich V.S., Drapkina O.M., Duplyakov D.V., Yeregin S.Ya., Zubareva M.Yu., Karpov R.S., Karpov Yu.Aet al. Diagnosis and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis, Atherosclerosis and Dyslipidemia. 2017; 3: 5-22 (In Russian)
|
|